Cardiovascular disease in Africa: epidemiological profile and challenges

Ashley K Keates1, Ana O Mocumbi2, Mpiko Ntsekhe3

  • 1Mary MacKillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, Victoria 3000, Australia.

Nature Reviews. Cardiology
|February 24, 2017
PubMed

Insights

Cardiovascular disease (CVD) disproportionately affects Africa. Rising noncommunicable CVD risk from hypertension, smoking, and obesity, alongside existing diseases, demands better data for effective public health strategies.

Area of Science:

  • Public Health
  • Epidemiology
  • Cardiology

Background:

  • Cardiovascular disease (CVD) poses a significant and growing health challenge in Africa.
  • The continent's diverse populations experience a complex interplay of communicable and noncommunicable disease pathways leading to CVD.
  • Factors like hypertension, smoking, and obesity are increasing the risk of noncommunicable CVD.

Purpose of the Study:

  • To present a contemporary overview of cardiovascular disease epidemiology in Africa.
  • To identify and discuss regional disparities in CVD prevalence and risk factors.
  • To highlight knowledge gaps in understanding the full burden of CVD across African populations.

Main Methods:

  • Review of existing epidemiological data and literature on cardiovascular disease in Africa.
  • Analysis of regional variations in CVD incidence, risk factors, and disease types.
  • Synthesis of current knowledge and identification of areas requiring further research.

Main Results:

  • Cardiovascular disease disproportionately impacts the large and diverse African population.
  • Future CVD burden is expected to rise due to increasing rates of hypertension, smoking, and obesity.
  • Both historically prevalent (e.g., rheumatic heart disease) and emerging CVDs (e.g., coronary artery disease) are significant concerns.

Conclusions:

  • Accurate and current epidemiological data are crucial for developing effective CVD reduction strategies in Africa.
  • Addressing the evolving CVD burden requires understanding regional differences and knowledge gaps.
  • There is an urgent need for comprehensive data to combat the increasing prevalence of cardiovascular disease across the continent.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1000
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.4K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
786
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.0K